[HTML][HTML] Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines
…, JL Burgess, AL Naleway, H Tyner… - … England Journal of …, 2021 - Mass Medical Soc
Background Information is limited regarding the effectiveness of the two-dose messenger
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in …
[HTML][HTML] Protection with a third dose of mRNA vaccine against SARS-CoV-2 variants in frontline workers
…, N Schaefer-Solle, JM Jones, H Tyner… - … England Journal of …, 2022 - Mass Medical Soc
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline
Workers | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram …
Workers | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram …
Propionibacterium acnes biofilm–A sanctuary for Staphylococcus aureus?
H Tyner, R Patel - Anaerobe, 2016 - Elsevier
The purpose of this study was to measure the effect of combined culture of Propionibacterium
acnes and Staphylococcus aureus on biofilm formation under different oxygen …
acnes and Staphylococcus aureus on biofilm formation under different oxygen …
[HTML][HTML] Fifteen-year clinical experience with Mycobacterium haemophilum at the Mayo Clinic: a case series
HL Tyner, JW Wilson - Journal of Clinical Tuberculosis and Other …, 2017 - Elsevier
Mycobacterium haemophilum is an uncommonly encountered acid-fast staining bacillus (AFB)
that can cause a broad range of infections. We describe a tertiary care center's …
that can cause a broad range of infections. We describe a tertiary care center's …
[HTML][HTML] Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER): protocol for a multisite longitudinal cohort study
…, P Kutty, ML Arvay, SK Yoon, HL Tyner… - JMIR research …, 2021 - researchprotocols.org
Background Workers critical to emergency response and continuity of essential services
during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. …
during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. …
[HTML][HTML] Risk factors for reinfection with SARS-CoV-2 Omicron variant among previously infected frontline workers
…, M Gaglani, AJ Caban-Martinez, HL Tyner… - Emerging infectious …, 2023 - ncbi.nlm.nih.gov
In a cohort of essential workers in the United States previously infected with SARS-CoV-2,
risk factors for reinfection included being unvaccinated, infrequent mask use, time since first …
risk factors for reinfection included being unvaccinated, infrequent mask use, time since first …
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study
…, JM Jones, A Britton, HL Tyner… - Clinical Infectious …, 2024 - academic.oup.com
Background There are limited data on whether hybrid immunity differs by count and order of
immunity-conferring events (SARS-CoV-2 infection or COVID-19 vaccination). From a cohort …
immunity-conferring events (SARS-CoV-2 infection or COVID-19 vaccination). From a cohort …
[HTML][HTML] COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers
Introduction In a multi-center prospective cohort of essential workers, we assessed knowledge,
attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and …
attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and …
Neutralizing antibody response to pseudotype severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differs between mRNA-1273 and BNT162b2 …
HL Tyner, JL Burgess, L Grant, M Gaglani… - Clinical infectious …, 2022 - academic.oup.com
Background Data on the development of neutralizing antibodies (nAbs) against SARS-CoV-2
after SARS-CoV-2 infection and after vaccination with mRNA COVID-19 vaccines are …
after SARS-CoV-2 infection and after vaccination with mRNA COVID-19 vaccines are …
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
…, RP Rai, S Saydah, N Smith, L Steinhardt, H Tyner… - JAMA, 2024 - jamanetwork.com
Importance Bivalent mRNA COVID-19 vaccines were recommended in the US for children
and adolescents aged 12 years or older on September 1, 2022, and for children aged 5 to 11 …
and adolescents aged 12 years or older on September 1, 2022, and for children aged 5 to 11 …